Matrixx gets big shake-up at top
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
Matrixx Initiatives – which markets the Zicam homoeopathic cold treatment brand – has shaken up its management team in the wake of its takeover by privateequity firm Gryphon Investors.